Efficacy and safety of anlotinib-based treatment in metastatic breast cancer patients

OBJECTIVE: To evaluate the efficacy and safety of anlotinib-based treatment in metastatic breast cancer (MBC) patients with failure of standard treatment. METHODS: We collected the medical data of 56 female patients with the diagnosis of MBC and had failed the standard treatment before. These patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Yu, Lou, Kexin, Zhou, Hao, Zhang, Lili, Yuan, Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780491/
https://www.ncbi.nlm.nih.gov/pubmed/36568219
http://dx.doi.org/10.3389/fonc.2022.1042451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780491/
https://www.ncbi.nlm.nih.gov/pubmed/36568219
http://dx.doi.org/10.3389/fonc.2022.1042451

Ejemplares similares